Detalles de la búsqueda
1.
Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses.
J Gastroenterol Hepatol
; 38(5): 724-732, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36692034
2.
Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.
Dig Dis Sci
; 68(3): 889-896, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35687221
3.
Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas.
Clin Gastroenterol Hepatol
; 20(6): 1306-1314, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389484
4.
Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study.
Med J Aust
; 214(3): 128-133, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33070332
5.
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.
Intern Med J
; 51(1): 106-110, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33572016
6.
Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
Dig Dis Sci
; 64(6): 1622-1631, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30560332
7.
Faecal calprotectin delivers on convenience, cost reduction and clinical decision-making in inflammatory bowel disease: a real-world cohort study.
Intern Med J
; 49(1): 94-100, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29962008
8.
Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis.
J Gastroenterol Hepatol
; 33(1): 226-231, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28618062
9.
Predicting response after infliximab salvage in acute severe ulcerative colitis.
J Gastroenterol Hepatol
; 33(7): 1347-1352, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29266456
10.
Predictive Scores in Acute Severe Ulcerative Colitis: Which, What, and When are the Decision Points We Should Target?
Clin Gastroenterol Hepatol
; 20(2): e344-e345, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33905768
11.
Anti-TNF-associated immunogenicity: use a retroactive drug but a proactive approach.
Gut
; 70(4): 812-813, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32680844
12.
Response to: Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlate With Rate of Infection.
Clin Gastroenterol Hepatol
; 19(5): 1077, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33249017
13.
Poor predictive value of breath hydrogen response for probiotic effects in IBS.
J Gastroenterol Hepatol
; 30(12): 1731-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26095068
14.
Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment?
Inflamm Bowel Dis
; 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38537201
15.
Clinical trial: Combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study).
Aliment Pharmacol Ther
; 59(4): 504-514, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38095246
16.
Replacing Endoscopy with Magnetic Resonance Enterography for Mucosal Activity Assessment in Terminal Ileal Crohn's Disease: Are We There Yet?
Diagnostics (Basel)
; 13(6)2023 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980368
17.
The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn's Disease: A Systematic Review and Meta-Analysis.
Biomedicines
; 11(5)2023 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37239079
18.
Utility of panenteric capsule endoscopy for the detection of small-bowel Crohn's disease in patients with a normal magnetic resonance enterography: A prospective observational pilot study.
JGH Open
; 7(12): 966-973, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38162838
19.
The Nocebo Effect in a Non-Medical Switching Program from Originator to Biosimilar Infliximab in Inflammatory Bowel Disease.
BioDrugs
; 36(5): 639-644, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35960446
20.
Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn's Disease.
Diagnostics (Basel)
; 12(10)2022 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36292222